References
- Kingman J, Callen JP. Keratoacanthoma. Arch Dermatol 1984; 120: 736–40
- Schwartz RA. The keratoacanthoma: a review. J Surg Oncol 1979; 12: 305–17
- Kopf A W, Bart RS. Development of more keratoacanthomas following skin testing with nitrogen mustard in a patient with multiple keratoacanthoma syndrome. J Dermatol Surg Oncol 1979; 5: 227–8
- Schwartz RA. Multiple persistent keratoacanthomas. Oncology 1979; 36: 281–5
- Shellito J E, Samet JM. Keratoacanthoma as a complication of arterial puncture for blood gases. Int J Dermatol 1982; 21: 349
- Haider S. Keratoacanthoma in a smallpox vaccination site. Br J Dermatol 1974; 90: 689–90
- Lloyd K M, Madsen D K, Lin PY. Grzybowski's eruptive keratoacanthoma. J Am Acad Dermatol 1989; 21: 1023–4
- Ghadially F N, Barton B W, Kerridge DF. The etiology of keratoacanthoma. Cancer 1963; 16: 603–11
- Rook A, Champion RH. Keratoacanthoma. Monogr Natl Cancer Inst 1963; 10: 257–73
- Zacarian SA. Cryogenics: the cryolesion and the pathogenesis of cryonecrosis. Cryosurgery for skin cancer and cutaneous disorders, SA Zacarian. CV Mosby, St. Louis 1985; 1–30; 96–162
- Yamagiwa K, Ichikawa K. Experimental study of the pathogenesis of carcinoma. J Cancer Res 1981; 3: 1–29
- Hodak E, Jones R E, Ackerman BA. Solitary keratoacanthoma is a squamous cell carcinoma: three examples with metastases. Am J Dermatopathol 1993; 15: 332–42
- Goldenhersh M A, Olsen TG. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma. J Am Acad Dermatol 1984; 10: 372–8
- Schwartz RA. Keratoacanthoma. J Am Acad Dermatol 1994; 30: 1–19
- Seidman J D, Berman J J, Moore GW, et al. Multiparameter DNA flow cytometry of keratoacanthoma. Anal Quant Cytol Histol 1992; 14: 113–19
- Moschella S L, Greenwald MA. Psoriasis with hydroxyurea: an 18-month study of 60 patients. Arch Dermatol 1973; 107: 363–8
- Spier A, Solomon L M, Esterly NB, et al. Hydroxyurea and macrocytosis. Br J Dermatol 1973; 89: 199–205
- Boyd A S, Meldner KH. Hydroxyurea therapy. J Am Acad Dermatol 1991; 25: 518–24
- Thurman W G, Watkins WL. Study of serum B12 and folate. Patients treated with hydroxyurea. Cancer Chemother Rep 1964; 40: 23–5
- Hunter G A, Simmons I J, Thomas BM. A clinical trial of hydroxyurea and psoriasis. Aust J Dermatol 1972; 13: 93–9
- Layton A M, Sheehan-Dare A, Goodfield M JD, et al. Hydroxyurea in the management of therapy resistant psoriasis. Br J Dermatol 1989; 121: 647–53
- Shuster S, Marks J. Dermatogenic enteropathy. A new cause of steatorrhoea. Lancet 1965; 1: 1367–8
- Harrison PV. Psoriasis, nails and auto immunity. Br J Dermatol 1990; 122: 569–70
- Reith R, Willianson J, Breathnach A, et al. Inhibition of vaccinia virus replication by azelaic acid. IRCS Med Sci 1985; 13: 783–4
- Bajor R, Holland K, Leemhy J, et al. Azelaic acid in Staphylococcus epidermidis NCTC 1 1047. J Appl Bacteriol 1988; 64: 497–504
- Maple P A, Hamilton Miller J M, Brumfilt W. Comparison of the in vitro activities of the topical antimicrobials azelaic acid, nitrofurazine, silver sulphadiazine and mupirocin against methicillin-resistant. Staphylococcus aureus. J Antimicrob Chemother 1992; 29: 661–8
- Brauch J, Friegl B. Dicarboxylic acid affects the growth of dermatophytes in vitro. Acta Derm Venereol 1994; 5: 347–50
- Detmar M, Mayer-de Silva A, Stadler R, et al. Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro. J Invest Dermatol 1989; 93: 70–4